Menu
GeneBe

rs72552065

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000719.7(CACNA1C):c.5292C>T(p.Asn1764=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0557 in 1,613,704 control chromosomes in the GnomAD database, including 2,891 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 192 hom., cov: 33)
Exomes 𝑓: 0.057 ( 2699 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.630
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 12-2679644-C-T is Benign according to our data. Variant chr12-2679644-C-T is described in ClinVar as [Benign]. Clinvar id is 136633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-2679644-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.63 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0634 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CACNA1CNM_000719.7 linkuse as main transcriptc.5292C>T p.Asn1764= synonymous_variant 42/47 ENST00000399655.6
CACNA1CNM_001167623.2 linkuse as main transcriptc.5292C>T p.Asn1764= synonymous_variant 42/47 ENST00000399603.6
CACNA1C-AS1NR_045725.1 linkuse as main transcriptn.334-1747G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CACNA1CENST00000399603.6 linkuse as main transcriptc.5292C>T p.Asn1764= synonymous_variant 42/475 NM_001167623.2 Q13936-37
CACNA1CENST00000399655.6 linkuse as main transcriptc.5292C>T p.Asn1764= synonymous_variant 42/471 NM_000719.7 Q13936-12
CACNA1C-AS1ENST00000501371.5 linkuse as main transcriptn.295-1747G>A intron_variant, non_coding_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0440
AC:
6702
AN:
152204
Hom.:
192
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0480
Gnomad ASJ
AF:
0.0953
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0112
Gnomad FIN
AF:
0.0494
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0650
Gnomad OTH
AF:
0.0463
GnomAD3 exomes
AF:
0.0449
AC:
11087
AN:
246974
Hom.:
383
AF XY:
0.0455
AC XY:
6102
AN XY:
134182
show subpopulations
Gnomad AFR exome
AF:
0.00946
Gnomad AMR exome
AF:
0.0283
Gnomad ASJ exome
AF:
0.0941
Gnomad EAS exome
AF:
0.000334
Gnomad SAS exome
AF:
0.0132
Gnomad FIN exome
AF:
0.0504
Gnomad NFE exome
AF:
0.0648
Gnomad OTH exome
AF:
0.0553
GnomAD4 exome
AF:
0.0569
AC:
83126
AN:
1461382
Hom.:
2699
Cov.:
32
AF XY:
0.0559
AC XY:
40660
AN XY:
726966
show subpopulations
Gnomad4 AFR exome
AF:
0.0101
Gnomad4 AMR exome
AF:
0.0299
Gnomad4 ASJ exome
AF:
0.0901
Gnomad4 EAS exome
AF:
0.000277
Gnomad4 SAS exome
AF:
0.0135
Gnomad4 FIN exome
AF:
0.0522
Gnomad4 NFE exome
AF:
0.0644
Gnomad4 OTH exome
AF:
0.0552
GnomAD4 genome
AF:
0.0440
AC:
6698
AN:
152322
Hom.:
192
Cov.:
33
AF XY:
0.0432
AC XY:
3219
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.0110
Gnomad4 AMR
AF:
0.0479
Gnomad4 ASJ
AF:
0.0953
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0114
Gnomad4 FIN
AF:
0.0494
Gnomad4 NFE
AF:
0.0650
Gnomad4 OTH
AF:
0.0458
Alfa
AF:
0.0604
Hom.:
183
Bravo
AF:
0.0430
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0662
EpiControl
AF:
0.0651

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 16, 2013- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 10, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Long QT syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 17, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
Cadd
Benign
0.61
Dann
Benign
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72552065; hg19: chr12-2788810; COSMIC: COSV59719622; COSMIC: COSV59719622; API